Eli Lilly price target raised to $1,250 from $1,060 at Citi | Nasdaq

Eli Lilly Price Target Raised To $1,250 From $1,060 At Citi | Nasdaq

3 weeks from now

Oct 25, 2024  · Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of analyst coverage. GLP-1 adoption has fueled …

nasdaq.com

Brokerages Set Eli Lilly And Company (NYSE:LLY) Price Target At …

3 weeks from now

Dec 7, 2024  · Citigroup boosted their price objective on Eli Lilly and Company from $1,060.00 to $1,250.00 and gave the stock a "buy" rating in a report on Friday, October 25th. JPMorgan …

marketbeat.com

Eli Lilly And Company (NYSE:LLY) Stock Price Up 1.3% - MarketBeat

3 weeks from now

Dec 3, 2024  · Finally, Citigroup upped their price target on shares of Eli Lilly and Company from $1,060.00 to $1,250.00 and gave the stock a "buy" rating in a report on Friday, October 25th. …

marketbeat.com

Eli Lilly Stock Upgraded To "Buy" As Analysts Boost Price Target

3 weeks from now

Eli Lilly's Strong Pipeline and Earnings Lead to Stock Upgrade and Higher Price Target. ... raising its target price to $1,250 as the company’s future growth prospects continue to impress; ...

gurufocus.com

Eli Lilly Wins Buy As Citi Resumes Coverage On Obesity Prospects

3 weeks from now

After a period of rating suspensions, Citi resumed its coverage on Eli Lilly (NYSE:LLY) with a buy recommendation and a $1,060 price target, citing the company’s GLP-1 pipeline, including its ...

msn.com

Novo Obesity Data ‘nearly A Best-case’ For Eli Lilly, Says Citi

3 weeks from now

Dec 20, 2024  · The firm keeps a Buy rating on Eli Lilly with a $1,250 price target. The stock in premarket trading is up 8%, or $57.46, to $815.00. Pick the best stocks and maximize your …

nasdaq.com

What Is The Current Price Target And Forecast For Eli Lilly (LLY)

3 weeks from now

4 days ago  · The forecasts for Eli Lilly and Company (LLY) range from a low of $700 to a high of $1250. The average price target represents a increase of $30.24 from the last closing price of …

zacks.com

Eli Lilly And Company (NYSE:LLY) Trading Up 2.1% - Still A Buy?

3 weeks from now

Dec 23, 2024  · Citigroup raised their price objective on Eli Lilly and Company from $1,060.00 to $1,250.00 and gave the stock a "buy" rating in a report on Friday, October 25th. Sanford C. …

marketbeat.com

Citigroup Maintains Buy On Eli Lilly, Raises Price Target To $1250

3 weeks from now

Oct 25, 2024  · Citigroup analyst Peter Verdult maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1060 to $1250.

sahmcapital.com

Eli Lilly Stock Upgraded To "Buy" As Analysts Boost Price Target To …

3 weeks from now

1 day ago  · Truist Financial added its predicted price to improve from $1,000 to $1,033, delivering a 'buy,' and Deutsche Bank dropped its target to $1,015, in keeping with a 'buy,' however. …

tradingview.com

LLY Stock Price Target | Eli Lilly And Company Analyst Ratings

3 weeks from now

Boost Target: Buy Buy: $1,060.00 $1,250.00: i. Rating by P. Verdult at Citigroup Inc. ... Eli Lilly Stock Upgraded to "Buy" as Analysts Boost Price Target to $1,250; insidermonkey.com …

pricetargets.com

Eli Lilly And Company (LLY) Stock Forecast & Price Target

3 weeks from now

4 days ago  · According to the 21 analysts' twelve-month price targets for Eli Lilly and Company, the average price target is $1,002.22. The highest price target for LLY is $1,250.00, while the …

marketbeat.com

Eli Lilly Wins A New Street-High Price Target - Nasdaq

3 weeks from now

Jul 29, 2024  · Accordingly, Anderson has raised his price target on LLY from $909 to a Street-high of $1,117, suggesting the stock has another 36% of gains ahead of it. It hardly needs …

nasdaq.com

Healthcare Stocks Like Eli Lilly Are Set To Surge In 2025: Citi ...

3 weeks from now

Dec 26, 2024  · Citi analysts forecast 19% earnings growth for the healthcare sector in 2025, up from 4% this year. The analysts point to the stocks' right-sized valuations and a potential …

businessinsider.com

Eli Lilly Price Target Lowered To $1,015 From $1,025 At ... - Nasdaq

3 weeks from now

Nov 1, 2024  · Deutsche Bank analyst James Shin lowered the firm’s price target on Eli Lilly (LLY) to $1,015 from $1,025 and keeps a Buy rating on the shares. Following the Q3 earnings …

nasdaq.com

Eli Lilly Shares Jump Over 5% After It Raises Profit Estimates

3 weeks from now

Dec 15, 2021  · FXEmpire.com - Eli Lilly shares surged over 5% in pre-market trading on Wednesday after the Indianapolis-based pharmaceutical giant raised its full-year 2021 profit …

nasdaq.com